Login to Pancreatic Cancer UK

Preoperative endoscopic ultrasound for the diagnosis and personalised treatment of pancreatic cancer

Recipient: Mr Nigel Jamieson

Host Institution: University of Glasgow

Title: Preoperative endoscopic ultrasound for the diagnosis and personalised treatment of pancreatic cancer

Type of award: 2015 Research Innovation Fund

Funding: £75,000 (funded by Pancreatic Cancer UK, Pancreatic Cancer Scotland and the Chief Scientist Office).

Endoscopic ultrasound has been shown to be incredibly effective as a diagnostic tool for people with pancreatic cancer. It has also been proven to be safe and shown not to adversely impact on survival.

Mr Jamieson’s team believe the full potential of endoscopic ultrasound is yet to be realised. In this project the researchers will analyse tissue taken during the endoscopic ultrasound, looking at the specific functional characteristics of each patient’s individual pancreatic cancer.

From this analysis, the pancreatic cancer can be categorised and the optimal treatment selected. This ensures the highest chances of survival and minimises unwanted and unnecessary side effects from treatments that may be ineffective. This is a promising area of investigation through which the researchers could develop a safe and effective tool that could be used in a clinical setting. This would enable doctors to decide the most appropriate treatment for pancreatic cancer patients maximising their chances of survival.